Variational AI is a pioneering company that leverages generative artificial intelligence to revolutionize drug discovery. Their proprietary platform, Enki™, utilizes advanced machine learning algorithms to generate novel, drug-like small molecules tailored to specific therapeutic targets. By focusing on creating new molecules rather than screening existing ones, Variational AI aims to expedite the development of efficacious, safe, and synthesizable small molecule therapeutics, particularly in the field of oncology.